Blog

uniQure to Advance AMT-061 Gene Therapy for Hemophilia B to Clinical Trial in 2018 – Hemophilia News Today


Hemophilia News Today

uniQure to Advance AMT-061 Gene Therapy for Hemophilia B to Clinical Trial in 2018
Hemophilia News Today
uniQure plans to advance its investigational gene therapy AMT-061 into a pivotal study in 2018 for patients with severe and moderately severe hemophilia B. Gene therapies are being develop to treat diseases caused by genetic mutations. It involves …

2017-10-25 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.